Adult cardiomyocyte that has re-entered the cell cycle after expression of miR302-367. Credit: Lab of Ed Morrisey, PhD, Perelman School of Medicine, University of Pennsylvania
The heart tissue of mammals has limited capacity to regenerate after an injury such as a heart attack, in part due to the inability to reactivate a cardiac muscle cell and proliferation program. Recent studies have indicated a low level of cardiac muscle cell (cardiomyocytes) proliferation in adult mammals, but it is insufficient to repair damaged hearts.
A team led by Ed Morrisey, PhD, a professor of Medicine and Cell and Developmental Biology and the scientific director of the Institute for Regenerative Medicine in the Perelman School of Medicine at the University of Pennsylvania, has now shown that a subset of RNA molecules, called microRNAs, is important for cardiomyocyte cell proliferation during development and is sufficient to induce proliferation in cardiomyocytes in the adult heart. MicroRNAs, which do not generate proteins, repress gene expression by binding messenger RNAs, which do generate proteins, and promote their degradation. The findings appear this week in Science Translational Medicine.
The team found that the loss of the microRNA cluster miR302-367 in mice led to decreased cardiomyocyte cell proliferation during development. In contrast, increased expression of the microRNA cluster in adult hearts led to a reactivation of proliferation in the normally non-reproducing adult cardiomyocytes.
This reactivation occurred, in part, through repression of a pathway called Hippo that governs cell proliferation and organ size. "The Hippo pathway normally represses cell proliferation when it is turned on. The cluster miR302-367 targets three of the major kinase components in the Hippo pathway, reducing pathway activity, which allows cardiomyocytes to re-enter the cell cycle and begin to regrow heart muscle," explains Morrisey. "This is a case of repressing a repressor."
In adult mice, re-expression of the microRNA cluster reactivated the cell cycle in cardiomyocytes, resulting in reduced scar formation after an experimental myocardial infarction injury was induced in the mice. There was also an increase in the number of heart muscle cells in these same mice.
However, long-term expression of more than several months of the microRNA cluster caused heart muscle cells to de-differentiation and become less functional. "This suggested to us that persistent reactivation of the cell cycle in adult cardiomyocytes could be harmful and causes the heart to fail," says Morrisey. The investigators surmised that cardiomyocytes likely need to de-differentiate to divide, but they may lose their ability to contract over time.
"We overcame this limitation by injecting synthetic microRNAs with a short half-life called mimics into the mice," says Morrisey. Mimic treatment for seven days after cardiac infarction led to the desired increase in cardiomyocyte proliferation and regrowth of new heart muscle, which resulted in decreased fibrosis and improved heart function after injury.
Importantly, the team found that the transient seven-day treatment did not lead to the progressive loss of cardiac function as seen in the genetic models of increased microRNA expression. Overall, these results suggested that any treatment that promotes cardiomyocyte proliferation to improve cardiac regeneration will likely need to be transient to avoid the deleterious effects of maintaining a high level of proliferation and de-differentiation in a tissue that is normally non-proliferative.
"The next stage in this study is to determine whether miRNA mimics will work in a larger animal model and to collaborate with bioengineers to create a local delivery system for the heart, rather than giving it systemically," notes Morrisey.
Explore further: Delivering stem cells into heart muscle may enhance cardiac repair and reverse injury
More information: A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice, Science Translational Medicine, http://ift.tt/1pjWY9d scitranslmed.aaa7538
Medical Xpress on facebook
Related Stories
Breakthrough in adult heart repair
Nov 19, 2013
Researchers from the Baylor College of Medicine and the Texas Heart Institute have discovered a new way to dramatically improve heart repair. The future goal is to use this knowledge to combat human cardiovascular disease ...
Delivering stem cells into heart muscle may enhance cardiac repair and reverse injury
Nov 19, 2014
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented ...
Mammalian heart regenerative capacity depends on severity of injury
Jan 22, 2015
A new study by researchers at Children's Hospital Los Angeles has shown that neonatal mouse hearts have varying regenerative capacities depending upon the severity of injury. Using cryoinjury - damaging the ...
Long-term use of ventricular assist devices induces heart muscle regeneration, study finds
Jan 21, 2015
Prolonged use of a left ventricular assist device (LVAD) by patients with heart failure may induce regeneration of heart muscle by preventing oxidative damage to a cell-regulator mechanism, UT Southwestern ...
Process for expansion and division of heart cells identified
Feb 17, 2009
Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) and the University of California, San Francisco have unraveled a complex signaling process that reveals how different types of cells interact to create ...
Recommended for you
Healthy diet reduces risk of cardiovascular disease by a third in over-40s
2 hours ago
Men and women who adapt their daily diet to meet current UK dietary guidelines could reduce their risk of a heart attack or a stroke by up to a third, according to a new study by King's College London.
Use of anti-clotting drug more than three hours after stroke should be re-evaluated, say researchers
19 hours ago
Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.
Decline in heart health can start in childhood
22 hours ago
Your heart health, which is optimal for most of us at birth, can decline substantially with unhealthy childhood behaviors, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Associ ...
Duration of antiplatelet therapy following PCI, risk of adverse events
Mar 17, 2015
An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...
Trial of bivalirudin during angioplasty reports mixed results
Mar 17, 2015
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints—a composite of rate of death, heart ...
Hormones with statins may help women's hearts after menopause
Mar 17, 2015
Hormones may not protect women from heart disease or stroke after menopause, but when combined with cholesterol-lowering statin drugs, they may help protect women from these killers, shows a population study from Sweden to ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Adult cardiomyocyte that has re-entered the cell cycle after expression of miR302-367. Credit: Lab of Ed Morrisey, PhD, Perelman School of Medicine, University of Pennsylvania
The heart tissue of mammals has limited capacity to regenerate after an injury such as a heart attack, in part due to the inability to reactivate a cardiac muscle cell and proliferation program. Recent studies have indicated a low level of cardiac muscle cell (cardiomyocytes) proliferation in adult mammals, but it is insufficient to repair damaged hearts.
A team led by Ed Morrisey, PhD, a professor of Medicine and Cell and Developmental Biology and the scientific director of the Institute for Regenerative Medicine in the Perelman School of Medicine at the University of Pennsylvania, has now shown that a subset of RNA molecules, called microRNAs, is important for cardiomyocyte cell proliferation during development and is sufficient to induce proliferation in cardiomyocytes in the adult heart. MicroRNAs, which do not generate proteins, repress gene expression by binding messenger RNAs, which do generate proteins, and promote their degradation. The findings appear this week in Science Translational Medicine.
The team found that the loss of the microRNA cluster miR302-367 in mice led to decreased cardiomyocyte cell proliferation during development. In contrast, increased expression of the microRNA cluster in adult hearts led to a reactivation of proliferation in the normally non-reproducing adult cardiomyocytes.
This reactivation occurred, in part, through repression of a pathway called Hippo that governs cell proliferation and organ size. "The Hippo pathway normally represses cell proliferation when it is turned on. The cluster miR302-367 targets three of the major kinase components in the Hippo pathway, reducing pathway activity, which allows cardiomyocytes to re-enter the cell cycle and begin to regrow heart muscle," explains Morrisey. "This is a case of repressing a repressor."
In adult mice, re-expression of the microRNA cluster reactivated the cell cycle in cardiomyocytes, resulting in reduced scar formation after an experimental myocardial infarction injury was induced in the mice. There was also an increase in the number of heart muscle cells in these same mice.
However, long-term expression of more than several months of the microRNA cluster caused heart muscle cells to de-differentiation and become less functional. "This suggested to us that persistent reactivation of the cell cycle in adult cardiomyocytes could be harmful and causes the heart to fail," says Morrisey. The investigators surmised that cardiomyocytes likely need to de-differentiate to divide, but they may lose their ability to contract over time.
"We overcame this limitation by injecting synthetic microRNAs with a short half-life called mimics into the mice," says Morrisey. Mimic treatment for seven days after cardiac infarction led to the desired increase in cardiomyocyte proliferation and regrowth of new heart muscle, which resulted in decreased fibrosis and improved heart function after injury.
Importantly, the team found that the transient seven-day treatment did not lead to the progressive loss of cardiac function as seen in the genetic models of increased microRNA expression. Overall, these results suggested that any treatment that promotes cardiomyocyte proliferation to improve cardiac regeneration will likely need to be transient to avoid the deleterious effects of maintaining a high level of proliferation and de-differentiation in a tissue that is normally non-proliferative.
"The next stage in this study is to determine whether miRNA mimics will work in a larger animal model and to collaborate with bioengineers to create a local delivery system for the heart, rather than giving it systemically," notes Morrisey.
Explore further: Delivering stem cells into heart muscle may enhance cardiac repair and reverse injury
More information: A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice, Science Translational Medicine, http://ift.tt/1pjWY9d scitranslmed.aaa7538
Medical Xpress on facebook
Related Stories
Breakthrough in adult heart repair
Nov 19, 2013
Researchers from the Baylor College of Medicine and the Texas Heart Institute have discovered a new way to dramatically improve heart repair. The future goal is to use this knowledge to combat human cardiovascular disease ...
Delivering stem cells into heart muscle may enhance cardiac repair and reverse injury
Nov 19, 2014
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented ...
Mammalian heart regenerative capacity depends on severity of injury
Jan 22, 2015
A new study by researchers at Children's Hospital Los Angeles has shown that neonatal mouse hearts have varying regenerative capacities depending upon the severity of injury. Using cryoinjury - damaging the ...
Long-term use of ventricular assist devices induces heart muscle regeneration, study finds
Jan 21, 2015
Prolonged use of a left ventricular assist device (LVAD) by patients with heart failure may induce regeneration of heart muscle by preventing oxidative damage to a cell-regulator mechanism, UT Southwestern ...
Process for expansion and division of heart cells identified
Feb 17, 2009
Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) and the University of California, San Francisco have unraveled a complex signaling process that reveals how different types of cells interact to create ...
Recommended for you
Healthy diet reduces risk of cardiovascular disease by a third in over-40s
2 hours ago
Men and women who adapt their daily diet to meet current UK dietary guidelines could reduce their risk of a heart attack or a stroke by up to a third, according to a new study by King's College London.
Use of anti-clotting drug more than three hours after stroke should be re-evaluated, say researchers
19 hours ago
Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.
Decline in heart health can start in childhood
22 hours ago
Your heart health, which is optimal for most of us at birth, can decline substantially with unhealthy childhood behaviors, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Associ ...
Duration of antiplatelet therapy following PCI, risk of adverse events
Mar 17, 2015
An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...
Trial of bivalirudin during angioplasty reports mixed results
Mar 17, 2015
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints—a composite of rate of death, heart ...
Hormones with statins may help women's hearts after menopause
Mar 17, 2015
Hormones may not protect women from heart disease or stroke after menopause, but when combined with cholesterol-lowering statin drugs, they may help protect women from these killers, shows a population study from Sweden to ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment